If you enjoy this content, please share it with a colleague
RELATED CONTENT
September 29, 2009 - Positron Corp., a molecular imaging solutions company focused on nuclear cardiology, will attend the 14th Annual American Society of Nuclear Cardiology (ASNC) annual conference in Minneapolis, Minn. Oct. 1-4, to showcase their newly developed cardiac optimized PET scanner, the Attrius.
September 15, 2009 - Positron Corp. announced that the Ministry of Health and Long Term Care of Ontario, Canada is making positron emission tomography (PET) scanning a publicly insured health service available to cancer and cardiac patients under conditions where PET scans have been proven to be clinically effective.
May 1, 2009 - The FDA has approved Neusoft Positron Medical Systems 510(k) submission for its Attrius positron emission tomographyy (PET) scanner product line developed by Positron Corp. and its joint venture with Neusoft Medical Systems based in Shenyang, China.
March 4, 2009 - Positron Corp., a Cardiac Molecular Imaging Solutions Company, today released results from an independent study on radiation exposure of technologists administering FDG.
October 17, 2007 - Positron Corp. introduced its dedicated Cardiac PET system that is expected to receive 510k FDA ...
August 1, 2007 - Positron Corp. announced that a recent study by The State University of New York at Buffalo reveals that Positron Emission Tomography (PET) scanning when used as the first tool to diagnose heart-vessel blockages, is more accurate, less invasive and cost effective than SPECT imaging.